Cargando…
Retroperitoneal Lymph Node Dissection Should Be a Standard-of-Care Treatment Option For Stage II Seminoma
Autores principales: | Alsyouf, Muhannad, Daneshmand, Siamak |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9922910/ https://www.ncbi.nlm.nih.gov/pubmed/36793748 http://dx.doi.org/10.1016/j.euros.2022.10.021 |
Ejemplares similares
-
Retroperitoneal Lymph Node Dissection as Primary Treatment for Metastatic Seminoma
por: Hu, Brian, et al.
Publicado: (2018) -
Stage II Seminoma: Why Chemotherapy Should Remain a Standard
por: Naoun, Natacha, et al.
Publicado: (2023) -
Pelvic Lymph Node Dissection at the Time of Radical Prostatectomy: Extended, of Course
por: Gandaglia, Giorgio, et al.
Publicado: (2022) -
Stage II Seminoma: Is There Something New on the Horizon?
por: Albersen, Maarten, et al.
Publicado: (2023) -
The role of primary retroperitoneal lymph node dissection in the treatment of stage II seminoma
por: Sigg, Silvan, et al.
Publicado: (2023)